Viewing Study NCT05000892


Ignite Creation Date: 2025-12-24 @ 3:23 PM
Ignite Modification Date: 2025-12-30 @ 12:14 PM
Study NCT ID: NCT05000892
Status: RECRUITING
Last Update Posted: 2022-12-02
First Post: 2021-08-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module